Ratings by Roth/MKM (Dylan Dupuls)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/31/2023 | Aslan Pharma | ASLN | New Coverage | Buy (N/A) |
3.91 (0.60) |
-84.65% | Details | |
| 5/31/2023 | Terns Pharmaceuticals | TERN | New Coverage | Buy (N/A) |
10.85 (52.95) |
388.02% | Details | |
| 5/31/2023 | UBS AG | UBS | New Coverage | Buy (N/A) |
19.85 (50.80) |
155.92% | Details | |
| 5/31/2023 | Inventiva SA | IVA | New Coverage | Buy (N/A) |
2.82 (3.57) |
26.6% | Details | |
| 5/31/2023 | Viking Therapeutic | VKTX | New Coverage | Buy (N/A) |
21.31 (30.38) |
42.56% | Details |
